Track blood tests and biomarkers over time with privacy-first approach
Personalized precision medicine powered by AI for cancer therapy
Stage
Startup
Not given
Founded
2026
Not given
Based in
GE
US
Pricing model
Freemium
Contact for pricing
Pricing
Free plan at $0.00/mo with 3 document analyses per month; Personal plan at $4.99/mo or $49.99/yr with 10 document analyses and AI analysis; Family plan at $14.99/mo or $149.99/yr with 50 document analyses, AI analysis, and up to 5 family members.
Not given
Key features
Automatic PDF lab report analysis and extraction
Biomarker organization using LOINC standard
Interactive charts and timelines for trend visualization
Track hundreds of biomarkers including glucose, cholesterol, vitamins, hormones, thyroid markers
Biomarker history tracking over time
AI-powered insights from health data
Family member health profiles
Document history access
View previously generated reports
Analyzes digital pathology with no additional tissue staining required
Rapid results within 1-2 days after specimen receipt
Validated across diverse populations including African American and non-African American men
FDA De Novo authorization for prostate cancer risk stratification
Insurance coverage for Medicare and many commercial plans
Provides 5 and 10-year distant metastasis risk for breast cancer
Identifies breast cancer patients who benefit from chemotherapy
Included in NCCN Clinical Practice Guidelines for Prostate Cancer
What makes it different
Privacy-first design with data not used for AI model training
Automatic organization of lab reports using LOINC standard
Clear visualization of biomarker trends over time
Full user control over personal health data
No additional tissue preparation needed, uses existing H&E slides
Validated across multiple large randomized phase III clinical trials
FDA De Novo clearance as Software as a Medical Device
Financial assistance program to make tests affordable regardless of income
BioReport
ArteraAI